These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 12464360
21. Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs. Stewart JL, McMahon LR. J Pharmacol Exp Ther; 2010 Jul; 334(1):347-56. PubMed ID: 20375197 [Abstract] [Full Text] [Related]
22. Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A. Darmani NA. Neuropsychopharmacology; 2001 Feb; 24(2):198-203. PubMed ID: 11120402 [Abstract] [Full Text] [Related]
23. Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors. Landi M, Croci T, Rinaldi-Carmona M, Maffrand JP, Le Fur G, Manara L. Eur J Pharmacol; 2002 Aug 16; 450(1):77-83. PubMed ID: 12176112 [Abstract] [Full Text] [Related]
25. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. Gallate JE, Saharov T, Mallet PE, McGregor IS. Eur J Pharmacol; 1999 Apr 16; 370(3):233-40. PubMed ID: 10334497 [Abstract] [Full Text] [Related]
26. Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system. Braida D, Pozzi M, Cavallini R, Sala M. Neuroscience; 2001 Apr 16; 104(4):923-6. PubMed ID: 11457579 [Abstract] [Full Text] [Related]
33. Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract. Casu MA, Porcella A, Ruiu S, Saba P, Marchese G, Carai MA, Reali R, Gessa GL, Pani L. Eur J Pharmacol; 2003 Jan 10; 459(1):97-105. PubMed ID: 12505538 [Abstract] [Full Text] [Related]
34. Integrity of extracellular loop 1 of the human cannabinoid receptor 1 is critical for high-affinity binding of the ligand CP 55,940 but not SR 141716A. Murphy JW, Kendall DA. Biochem Pharmacol; 2003 May 15; 65(10):1623-31. PubMed ID: 12754098 [Abstract] [Full Text] [Related]
38. Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor. Calandra B, Portier M, Kernéis A, Delpech M, Carillon C, Le Fur G, Ferrara P, Shire D. Eur J Pharmacol; 1999 Jun 25; 374(3):445-55. PubMed ID: 10422789 [Abstract] [Full Text] [Related]
39. Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats. Wiley JL, Barrett RL, Lowe J, Balster RL, Martin BR. Neuropharmacology; 1995 Jun 25; 34(6):669-76. PubMed ID: 7566504 [Abstract] [Full Text] [Related]
40. The effects of delta9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors. Breivogel CS, Scates SM, Beletskaya IO, Lowery OB, Aceto MD, Martin BR. Eur J Pharmacol; 2003 Jan 17; 459(2-3):139-50. PubMed ID: 12524139 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]